MedPath

Effects of SIMEOX on Flow and Volume

Not Applicable
Withdrawn
Conditions
Healthy
Interventions
Device: SIMEOX
Registration Number
NCT03655860
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

This study will investigate the effects of the SIMEOX (an airway clearance device) on flow and volume generated in healthy subjects

Detailed Description

This is a pilot study assessing the effect of the SIMEOX device on flow and volume generated in healthy subjects.

Assessment of flow and volume will be performed before and during the application of the SIMEOX. Vital capacity and expiratory flow will be assessed.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Able to understand the instructions
Exclusion Criteria
  • Obesity (BMI > 30kg/m²)
  • Active smoker
  • Severe scoliosis
  • Cardiovascular ou neuromuscular disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SIMEOXSIMEOXUse of the device SIMEOX to exhale
Primary Outcome Measures
NameTimeMethod
Change in expiratory volume5min

Expiratory volume before and during the use of the SIMEOX will be compared

Change in expiratory volume flow rate5min

Expiratory flow rate before and during the use of the SIMEOX will be compared

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

William Poncin

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath